Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Premenopausal Breast Cancer
Interventions: DRUG: Leuprorelin acetate
Sponsor: Takeda